Ngā hua rapu - Elisabeth Ejerblad
- E whakaatu ana i te 1 - 4 hua o te 4
-
1
Obesity and Risk for Chronic Renal Failure mā Elisabeth Ejerblad, C. Michael Fored, Per Lindblad, Jon P. Fryzek, Joseph K. McLaughlin, Olof Nyrén
I whakaputaina 2006Artigo -
2
-
3
Acetaminophen, Aspirin, and Chronic Renal Failure mā C. Michael Fored, Elisabeth Ejerblad, Per Lindblad, Jon P. Fryzek, Paul W. Dickman, Lisa B. Signorello, Loren Lipworth, Carl‐Gustaf Elinder, William J. Blot, Joseph K. McLaughlin, Matthew M. Zack, Olof Nyrén
I whakaputaina 2001Artigo -
4
Clinical effect of increasing doses of lenalidomide in high-risk myelodysplastic syndrome and acute myeloid leukemia with chromosome 5 abnormalities mā Lars Möllgård, Leonie Saft, Marianne Bach Treppendahl, Ingunn Dybedal, Jan Maxwell Nørgaard, Jan Astermark, Elisabeth Ejerblad, Hege Garelius, Inge Høgh Dufva, Monika Jansson, Martin Jädersten, Lars Kjeldsen, Olle Linder, L. Nilsson, Hanne Vestergaard, Anna Porwit, Kirsten Grønbæk, Eva Hellström Lindberg
I whakaputaina 2011Artigo
Ngā utauta rapu:
Ngā marau whai pānga
Internal medicine
Medicine
Environmental health
Logistic regression
Population
Demography
Kidney disease
Risk factor
Sociology
Acetaminophen
Anesthesia
Anthropometry
Aspirin
Body mass index
Bone marrow
Cancer research
Case-control study
Chronic renal failure
Confidence interval
Creatinine
Diabetes mellitus
Disease
Endocrinology
Epidemiology
Intensive care medicine
Lenalidomide
Multiple myeloma
Myelodysplastic syndromes
Myeloid leukemia
Obesity